We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration

News   Nov 06, 2012

 
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
 
 
 

RELATED ARTICLES

New Test Helps ID Those at Risk for Five Deadly Diseases

News

Researchers propose that it is time for the biomedical community to consider this genomics approach in clinical care.

READ MORE

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

New Prostate Cancer Blood Test Detects Early Treatment Failure

News

This new liquid biopsy helps to track and respond to prostate cancer evolution, and identify emerging drug resistance.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE